Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | A3249 | IM / LA |
RECEIVED CORPORATE EMAIL SHOWING PT RECEIVED RSV PREVIOUSLY 12/19/2023. PATIENT IS EXPERIENCING NO ADVERSE REACTIONS TO DUPLICATE DOSE.
NONE LISTED BY PATIENT
NONE LISTED BY PATIENT
NKA